Poole Jonathan Insider Trades

Insider Trading History

Track insider trading activity for Poole Jonathan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $343k 16,004 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$548k 25,315 shares
$21.66
$21.43
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $43.1k 2,010 shares
Last Trade
May 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$43.5k 2,010 shares
$21.66
$21.43
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $0 0 shares
Last Trade
May 29, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$43.5k 2,010 shares
$21.66
$21.43
Acadia Pharmaceuticals
Acadia Pharmaceuticals ACAD
Director
Holding Value $160k 7,482 shares
Last Trade
Mar 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$389k 17,275 shares
$22.50
$21.43
Evelo Biosciences
Evelo Biosciences EVLO
CFO
Holding Value $10.6 106,000 shares
Last Trade
Jan 28, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$435M 154,000 shares
$2,824.00
$0.00
Evelo Biosciences
Evelo Biosciences EVLO
CFO
Holding Value $10 100,000 shares
Last Trade
Jan 14, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$548M 100,000 shares
$5,484.00
$0.00
Evelo Biosciences
Evelo Biosciences EVLO
CFO
Holding Value $7.15 71,497 shares
Last Trade
May 08, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Evelo Biosciences
Evelo Biosciences EVLO
CFO
Holding Value $0 0 shares
Last Trade
May 08, 2018 Sale
No data
No data
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
Chief Financial Officer
Holding Value $21.8 217,708 shares
Last Trade
Feb 08, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.71M 217,708 shares
$7.84
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
Chief Financial Officer
Holding Value $8.42 84,247 shares
Last Trade
Jul 24, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.1M 45,000 shares
$46.64
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
Chief Financial Officer
Holding Value $9 90,000 shares
Last Trade
Jul 24, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.1M 45,000 shares
$46.64
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
Chief Financial Officer
Holding Value $3.92 39,247 shares
Last Trade
Jul 24, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.1M 45,000 shares
$46.64
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
Chief Financial Officer
Holding Value $3.92 39,247 shares
Last Trade
May 10, 2017 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$174k 3,500 shares
$49.68
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
Chief Financial Officer
Holding Value $4.27 42,747 shares
Last Trade
May 08, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$323k 6,213 shares
$51.92
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
Chief Financial Officer
Holding Value $4.9 48,960 shares
Last Trade
May 03, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.6M 31,747 shares
$50.40
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
Chief Financial Officer
Holding Value $13.5 135,000 shares
Last Trade
Feb 28, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.04M 135,000 shares
$37.36
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
Chief Financial Officer
Holding Value $1.72 17,213 shares
Last Trade
Nov 07, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$198k 7,000 shares
$28.32
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
Chief Financial Officer
Holding Value $0.821 8,213 shares
Last Trade
May 09, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$125k 4,000 shares
$31.20
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
Chief Financial Officer
Holding Value $13.5 135,000 shares
Last Trade
Feb 02, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.34M 135,000 shares
$24.72
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
Chief Financial Officer
Holding Value $9.5 95,000 shares
Last Trade
Feb 26, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.9M 95,000 shares
$72.64
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up